A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Multicenter Study to Assess the Feasibility of 5-Aminolevulinic Acid (5-ALA) in Pediatric Brain Tumor Patients	Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder	Not yet recruiting	Phase 2	2026-10-07		NCT06907485

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Advocate Hospital System	2
Costas Hadjipanayis	1
Neuroscience Research Foundation	1
NX Development Corp	2
Southeastern Brain Tumor Foundation	1
StacheStrong Foundation	1
University of Pittsburgh Medical Center	35

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
MidWest Children's Brain Tumor Center, Advocate Children's Hospital Park Ridge	Chicago	United States	1
UPMC Children's Hospital of Pittsburgh	Pittsburgh	United States	70